Table 3.
Univariate Analysis for Predictors the Pathological Response
| Pathological complete response |
Non-pathological complete response |
||||||
|---|---|---|---|---|---|---|---|
| pCR |
Non-pCR |
||||||
| OR | 95%CI | OR | 95%CI | P value | |||
| Variate | Lower | Upper | Lower | Upper | |||
| Age | 0.56 | 0.241 | 1.303 | 1.768 | 0.767 | 4.156 | 0.1 |
| Menopause | |||||||
| Pre vs post | 0.688 | 0.311 | 1.52 | 1.454 | 0.658 | 3.214 | 0.3 |
| Pathology | |||||||
| IDC vs non IDC | 0.224 | 0.075 | 0.665 | 4.469 | 1.503 | 13.287 | 0.007* |
| Grade | |||||||
| II vs III | 1.444 | 0.602 | 3.465 | 0.692 | 0.289 | 1.661 | 0.4 |
| LVI | |||||||
| Yes or No | 0.573 | 0.215 | 1.039 | 2.114 | 0.963 | 4.641 | 0.06* |
| Tumor size | 1.174 | 0.523 | 5.823 | 0.852 | 0.269 | 2.694 | 0.7 |
| LN | 0.706 | 0.147 | 3.395 | 1.417 | 0.295 | 6.814 | 0.6 |
| Ki 67 | |||||||
| Low vs high | 9.212 | 2.521 | 33.66 | 0.109 | 0.03 | 0.397 | 0.001* |
| TNBC | |||||||
| AR+ vs AR- | 7.96 | 2.492 | 25.427 | 0.126 | 0.039 | 0.401 | 0.001* |
IDC, invasive duct carcinoma; LVI, lymphovascular space invasion; T, tumor size; LN; lymph node status; TNBC, triple negative breast cancer; AR+, androgen receptor positive; AR-, androgen receptor negative. *P value < 0.05 significant.